Aisling Capital Management as of Sept. 30, 2023
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 17 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 65.9 | $160M | 6.1M | 26.37 | |
| Verona Pharma Sponsored Ads (VRNA) | 7.5 | $18M | 1.1M | 16.30 | |
| Syndax Pharmaceuticals (SNDX) | 6.1 | $15M | 1.0M | 14.52 | |
| Biomea Fusion (BMEA) | 4.5 | $11M | 799k | 13.76 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.9 | $7.1M | 965k | 7.40 | |
| Monte Rosa Therapeutics (GLUE) | 2.9 | $7.1M | 1.5M | 4.79 | |
| Reneo Pharmaceuticals (RPHM) | 2.8 | $6.7M | 886k | 7.61 | |
| Nuvation Bio Com Cl A (NUVB) | 1.4 | $3.4M | 2.5M | 1.34 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $3.0M | 435k | 6.85 | |
| Spruce Biosciences (SPRB) | 1.1 | $2.7M | 1.2M | 2.26 | |
| Poseida Therapeutics I (PSTX) | 1.0 | $2.5M | 1.0M | 2.38 | |
| Elevation Oncology (ELEV) | 0.8 | $1.9M | 2.8M | 0.66 | |
| Avrobio Ord (AVRO) | 0.6 | $1.6M | 1.0M | 1.54 | |
| Marker Therapeutics (MRKR) | 0.6 | $1.4M | 314k | 4.54 | |
| Aeglea Biotherapeutics Com New (SYRE) | 0.3 | $829k | 68k | 12.25 | |
| Viracta Therapeutics (VIRX) | 0.1 | $300k | 289k | 1.04 | |
| Atreca Cl A Com (BCEL) | 0.0 | $101k | 388k | 0.26 |
